Eli Van Allen
@VanAllenLab
Clinical Computational Oncology @DanaFarber @harvardmed @broadinstitute | Chief - Population Sciences | Prev.: @Stanford @UCLA @UCSF | Discl.: http://bit.ly/2kF9C7B
There’s never been a more exciting time for all of us to take on cancer, together.
Reminded today of how lucky I am to work with a multi-ethnic/racial/gender/religious/national team united in the fight against cancer
We examined the present and future of AI and translational cancer research for @Cancer_Cell - check out superstar @JoYatesResearch below for more on this perspective! @DanaFarberNews
Excited to share our new paper, "New horizons at the interface of artificial intelligence and translational cancer research", out now in @Cancer_Cell ! With @VanAllenLab, we explore how AI is reshaping oncology—from discovery to the clinic. 🔗 sciencedirect.com/science/articl…
1/ Thrilled to share our work on Chromophobe RCC (ChRCC) and Renal Oncocytic Neoplasms (RONs) out @JCO_ASCO !!! Incredibly thankful to my mentors @BraunMDPhD @DrChoueiri @VanAllenLab and all co-authors @DanaFarber @BIDMC_IM @Yale @BrighamWomens Link: ascopubs.org/doi/10.1200/JC…
Here's our latest, led by superstars @JoYatesResearch & Dr. Camille Mathey-Andrews, jointly with @val_boeva and many more @DanaFarberNews @broadinstitute We studied primary & lethal esophageal cancer using multi[RNA, ATAC, spatial]-omics, see Josephine's tweets below for more!👇
Thrilled to share our new paper out today in Cell Reports Medicine! @VanAllenLab @val_boeva We map cell states & neighborhoods across clinical stages of esophageal adenocarcinoma (EAC) using single-cell, epigenomic & spatial data.🔗cell.com/cell-reports-m… (1/9)
The only cool kid in high school who actually talked to me has a new book out - congrats @Passionweiss!: us.macmillan.com/books/97803746…
June 4, 2000 - Kobe and Shaq lead one of the greatest comebacks in Lakers history 👏
Nobel laureate Bill Kaelin on Killing the Science Golden Goose. "This is especially worrisome because becoming a scientist is largely taught by apprenticeship, with each generation teaching the next. We risk losing the next generation, our “seed corn”" amjmed.com/article/S0002-…
Finally out at @CellCellPress, our latest contribution to proteogenomics with #CPTAC The impact of germline variants to the cancer proteome As always, super fun and exciting to work with @DingLab_WashU Matt Bailey, and this time even with @MarigortaLab cell.com/cell/fulltext/…
The New York Times recently had an article on IVF and embryo selection which I think buries a few important ledes about these products ...
These points are mostly glossed over in the article, which focuses more on fantastical GATTACA scenarios and social media controversies. I get that those are more fun to cover and read about, but I think it is worth first resolving the question: does this tech even work at all?
📣 Excited to announce the launch of a new patient-partnered research project today – @CountMeIn’s Translocation Renal Cell Carcinoma Project! Delighted to co-PI this project alongside Dr. Elizabeth Mullen ➡️ tRCCproject.org. @DanaFarber @BostonChildrens @broadinstitute
We're honored to launch our latest project on translocation renal cell carcinoma (tRCC) - a rare, aggressive kidney cancer. With few treatment options, the tRCC Project partners with patients, caregivers & advocates to drive research forward. Learn more: hubs.ly/Q03bhbST0
Here's our latest - on strategies to compare groups of cancer patients using single cell data for hypothesis generation - led by superstar @sjohri20 @BBS_Harvard @DanaFarber et al See Shreya's thread for more details 👇
🚀Excited to share our new paper, now published in @NatureComms! ✨ We present BEANIE, a nonparametric method that reduces false positives when analyzing differential gene signature expression in multi-patient clinical scRNA-seq cohorts @VanAllenLab 🧪🧵nature.com/articles/s4146…
Again: what’s the vision here? We’re slashing NIH and NSF so … what? Basic health research is some of the best bang for buck in govt. And it can be much, much better than status quo. What’s the plan to supercharge American science to usher in our “golden age”? Where is it??
🚀Excited to share our new paper, now published in @NatureComms! ✨ We present BEANIE, a nonparametric method that reduces false positives when analyzing differential gene signature expression in multi-patient clinical scRNA-seq cohorts @VanAllenLab 🧪🧵nature.com/articles/s4146…